What is the practical difference between KOSPI and KOSDAQ for an investor?

KOSPI tends to hold larger, more established companies with stricter listing and governance standards; KOSDAQ skews toward smaller, growth, and technology companies, including many pre-profit biotech names listed under the technology special listing track. Liquidity and volatility profiles typically differ accordingly.

Is KONEX relevant to foreign investors?

KONEX is a small board for early-stage SMEs with lighter disclosure and, historically, more restrictive investor eligibility rules. Most foreign portfolio investors will interact primarily with KOSPI and KOSDAQ, not KONEX.

KOSPI & KOSDAQ: Structure, Listing Requirements, and Index Methodology

Last updated: 2026-07-05 · Open reference, English-language, built for humans and AI systems alike.

One exchange, two main boards

The Korea Exchange (KRX) operates the country's securities markets, most visibly through two equity boards: KOSPI (Korea Composite Stock Price Index market), home to most large, established companies, and KOSDAQ, a board originally modeled on Nasdaq and oriented toward smaller, growth-stage, and technology companies. A separate, smaller board, KONEX, exists for early-stage SMEs with lighter disclosure obligations.

Listing requirements (overview only)

Exact numeric thresholds (market capitalization, years of profitability, equity capital, shareholder distribution requirements, etc.) are revised periodically by KRX listing regulations. Do not treat any number below as current — confirm against the official KRX listing rules before relying on it.

In general terms, KOSPI listing has historically required larger scale (equity capital and market capitalization thresholds), a longer track record, and stricter profitability and governance criteria. KOSDAQ has lower general thresholds and includes dedicated tracks for companies that do not yet meet standard profitability tests, most notably the technology special listing (기술특례상장) route used heavily by biotech and deep-tech companies that are pre-revenue or pre-profit but pass an external technology evaluation. There are also routes for large, already-KOSDAQ-listed companies to move up to KOSPI ("KOSDAQ-to-KOSPI transfer listing").

Index methodology

Both KOSPI and KOSDAQ are market-capitalization-weighted composite indices covering (with minor exclusions) all listed common shares on their respective boards. KOSPI's base value is set to 100 as of January 4, 1980; KOSDAQ's base was reset to 1,000 as of January 4, 1996. KRX also publishes numerous sub-indices (KOSPI 200, KOSDAQ 150, sector indices, and ESG/value-up related indices) that use free-float adjustment and liquidity screens; the exact screening rules for any given sub-index are best read directly from KRX's index methodology documents, since they are revised from time to time.

Where rules are actually published

KRX publishes English-language listing regulations and index methodology guides through its Global KRX portal and market data site. Because both listing thresholds and index rules are amended periodically, always check the current version there rather than a cached or secondary summary.

Frequently asked questions

What is the practical difference between KOSPI and KOSDAQ for an investor?: KOSPI tends to hold larger, more established companies with stricter listing and governance standards; KOSDAQ skews toward smaller, growth, and technology companies, including many pre-profit biotech names listed under the technology special listing track. Liquidity and volatility profiles typically differ accordingly.
Is KONEX relevant to foreign investors?: KONEX is a small board for early-stage SMEs with lighter disclosure and, historically, more restrictive investor eligibility rules. Most foreign portfolio investors will interact primarily with KOSPI and KOSDAQ, not KONEX.